Hedge Funds Aren't Crazy About Turning Point Therapeutics, Inc. (TPTX) Anymore
In this article we are going to use hedge fund sentiment as a tool and determine whether Turning Point Therapeutics, Inc. (NASDAQ:TPTX) is a good investment right now.
Turning Point Therapeutics Inc. (TPTX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Vazirani Asset Management Raj Vazirani | 0 | $0 | 0% | |
| 2. | Weiss Asset Management Andrew Weiss | 0 | $0 | 0% | |
| 3. | Birchview Capital Matthew Strobeck | 0 | $0 | 0% | |
| 4. | Neo Ivy Capital Renee Yao | 0 | $0 | 0% | |
| 5. | Algert Coldiron Investors Peter Algert And Kevin Coldiron | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $81.34 | 2,000 | Director | 2,000 | 2021-06-21 | Filing | |
| $60.00 | 83,333 | Director | 2,253,660 | 2020-05-21 | Filing | |
| $60.00 | 4,166 | Officer, Director | 26,872 | 2020-05-21 | Filing | |
| $60.00 | 83,333 | Director | 2,253,660 | 2020-05-21 | Filing | |
| $45.00 | 177,777 | Director | 2,170,327 | 2019-09-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $74.94 | 1,183 | Officer | 28,700 | 2022-07-27 | Filing | |
| $36.30 | 397 | Officer | 3,448 | 2022-02-09 | Filing | |
| $36.30 | 221 | Officer | 22,078 | 2022-02-09 | Filing | |
| $36.30 | 669 | Officer | 11,696 | 2022-02-09 | Filing | |
| $36.30 | 669 | Officer | 6,838 | 2022-02-09 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Turning Point Therapeutics, Inc. (TPTX) Fell Out Of Favor With Hedge Funds
Is Turning Point Therapeutics, Inc.
Where Do Hedge Funds Stand On Turning Point Therapeutics, Inc. (TPTX)?
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending, many smart money investors are starting to get cautious...
Hedge Fund and Insider Trading News: Ray Dalio, White Square Capital, VGI Partners Limited, Alden Global Capital, Convey Holding Parent Inc (CNVY), Allegion PLC (ALLE), and More
A London-based hedge fund that took a hit from betting against GameStop is shutting down after reviewing its business model, the Financial Times reported on Tuesday.
Is TPTX Stock A Buy or Sell?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Top 10 Healthcare Stocks To Buy for the Future
Small- and mid-cap biotech and pharmaceutical companies represent some of the most compelling gambles available on the market.
Hedge Funds Turning More Bullish On Turning Point Therapeutics, Inc. (TPTX)
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file by the SEC.
Did Hedge Funds Make The Right Call On Turning Point Therapeutics, Inc. (TPTX) ?
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC.
Hedge Funds Have Never Been This Bullish On Turning Point Therapeutics, Inc. (TPTX)
We hate to say this but, we told you so.
Hedge Funds Have Never Been This Bullish On Turning Point Therapeutics, Inc. (TPTX)
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.